Tarsus Pharmaceuticals (TARS) Tax Rate (2020 - 2026)
Tarsus Pharmaceuticals (TARS) posted quarterly Tax Rate of 53.0% for Q1 2026, down 238382.69% quarter-over-quarter from 0.02% in Q3 2022.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Tax Rate (2020 - 2026) Analysis & Trends
Tarsus Pharmaceuticals' Tax Rate history runs 4 years deep, the most recent figure standing at 53.0% for Q1 2026.
- In Q1 2026, Tax Rate changed N/A year-over-year to 53.0%; the TTM figure through Mar 2026 stood at 1.64% (changed N/A YoY), while the FY2025 annual figure was 3.2%, changed N/A from the prior year.
- Tax Rate for Q1 2026 stood at 53.0%, down from 0.02% in the prior quarter.
- The five-year high for Tax Rate was 0.02% in Q3 2022, with the low at 53.0% in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Tarsus Pharmaceuticals | 3.96 Bn | 3.51 Bn | 161.80 Mn | -14.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14.79% |
| Mar 31, 2026 | -53.00% |
| Sep 30, 2022 | 0.02% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.37% |
| Sep 30, 2021 | 2.17% |
| Jun 30, 2021 | 0.40% |
| Mar 31, 2021 | 2.92% |
| Sep 30, 2020 | -0.01% |